CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 91 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 3.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $188,000 | -53.2% | 16,761 | -43.0% | 0.05% | -52.8% |
Q1 2016 | $402,000 | -28.0% | 29,400 | 0.0% | 0.11% | -27.5% |
Q4 2015 | $558,000 | +62.7% | 29,400 | +60.7% | 0.15% | +104.1% |
Q3 2015 | $343,000 | +34200.0% | 18,300 | +13976.9% | 0.07% | – |
Q2 2014 | $1,000 | – | 130 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |